These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 19925442)
1. Recent patents review in microencapsulation of pharmaceuticals using the emulsion solvent removal methods. Obeidat WM Recent Pat Drug Deliv Formul; 2009 Nov; 3(3):178-92. PubMed ID: 19925442 [TBL] [Abstract][Full Text] [Related]
2. The parameters influencing the morphology of poly(ɛ-caprolactone) microspheres and the resulting release of encapsulated drugs. Bile J; Bolzinger MA; Vigne C; Boyron O; Valour JP; Fessi H; Chevalier Y Int J Pharm; 2015 Oct; 494(1):152-66. PubMed ID: 26235922 [TBL] [Abstract][Full Text] [Related]
3. Microencapsulation of ibuprofen and Eudragit RS 100 by the emulsion solvent diffusion technique. Perumal D Int J Pharm; 2001 May; 218(1-2):1-11. PubMed ID: 11337145 [TBL] [Abstract][Full Text] [Related]
4. Control of encapsulation efficiency in polymeric microparticle system of tolmetin. Jelvehgari M; Valizadeh H; Rezapour M; Nokhodchi A Pharm Dev Technol; 2010; 15(1):71-9. PubMed ID: 19505209 [TBL] [Abstract][Full Text] [Related]
5. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques. Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795 [TBL] [Abstract][Full Text] [Related]
6. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. Rosca ID; Watari F; Uo M J Control Release; 2004 Sep; 99(2):271-80. PubMed ID: 15380636 [TBL] [Abstract][Full Text] [Related]
7. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles. Nilkumhang S; Basit AW Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519 [TBL] [Abstract][Full Text] [Related]
8. Single emulsion-solvent evaporation technique and modifications for the preparation of pharmaceutical polymeric nanoparticles. Nava-Arzaluz MG; Piñón-Segundo E; Ganem-Rondero A; Lechuga-Ballesteros D Recent Pat Drug Deliv Formul; 2012 Dec; 6(3):209-23. PubMed ID: 22734869 [TBL] [Abstract][Full Text] [Related]
9. Development of PEG-PLA/PLGA microparticles for pulmonary drug delivery prepared by a novel emulsification technique assisted with amphiphilic block copolymers. Takami T; Murakami Y Colloids Surf B Biointerfaces; 2011 Oct; 87(2):433-8. PubMed ID: 21715147 [TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique. Becker Peres L; Becker Peres L; de Araújo PHH; Sayer C Colloids Surf B Biointerfaces; 2016 Apr; 140():317-323. PubMed ID: 26764112 [TBL] [Abstract][Full Text] [Related]
11. Novel microparticle drug delivery systems based on chitosan and Eudragit® RSPM to enhance diltiazem hydrochloride release property. Cetin EO; Gundogdu E; Kirilmaz L Pharm Dev Technol; 2012; 17(6):741-6. PubMed ID: 21563988 [TBL] [Abstract][Full Text] [Related]
12. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Wischke C; Schwendeman SP Int J Pharm; 2008 Dec; 364(2):298-327. PubMed ID: 18621492 [TBL] [Abstract][Full Text] [Related]
13. Microparticles in the Development and Improvement of Pharmaceutical Formulations: An Analysis of In Vitro and In Vivo Studies. da Silva RYP; de Menezes DLB; Oliveira VDS; Converti A; de Lima ÁAN Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982517 [TBL] [Abstract][Full Text] [Related]
14. Solvent hydrolysis rate determines critical quality attributes of PLGA microspheres prepared using non-volatile green solvent. Kim H; Kim S; Sah H J Biomater Sci Polym Ed; 2018 Jan; 29(1):35-56. PubMed ID: 29086633 [TBL] [Abstract][Full Text] [Related]
15. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Yeo Y; Park K Arch Pharm Res; 2004 Jan; 27(1):1-12. PubMed ID: 14969330 [TBL] [Abstract][Full Text] [Related]
16. Incorporation of small molecular weight active agents into polymeric components. Iconomopoulou SM; Kallitsis JK; Voyiatzis GA Recent Pat Drug Deliv Formul; 2008; 2(2):94-107. PubMed ID: 19075901 [TBL] [Abstract][Full Text] [Related]
17. Review Article: Fabricated Microparticles: An Innovative Method to Minimize the Side Effects of NSAIDs in Arthritis. Abadi SS; Moin A; Veerabhadrappa GH Crit Rev Ther Drug Carrier Syst; 2016; 33(5):433-488. PubMed ID: 27910742 [TBL] [Abstract][Full Text] [Related]
18. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Tran VT; Benoît JP; Venier-Julienne MC Int J Pharm; 2011 Apr; 407(1-2):1-11. PubMed ID: 21256947 [TBL] [Abstract][Full Text] [Related]
19. Overview on Therapeutic Applications of Microparticulate Drug Delivery Systems. Bale S; Khurana A; Reddy AS; Singh M; Godugu C Crit Rev Ther Drug Carrier Syst; 2016; 33(4):309-361. PubMed ID: 27910739 [TBL] [Abstract][Full Text] [Related]